Bridging the gap at Queen Mary University of London

The MedTech SuperConnector (MTSC) empowers researchers to translate research from the arts and sciences into early-stage medical technologies.

Six QMUL researchers have been supported by the programme. The supported ventures include digital solutions for mental health & wellbeing, innovations in skin health and devices to monitor & manage gut pain.

The researchers have brought in £582,359.97 in funding to the institution through the support of five projects across both Challenge and Venture-led Accelerator Programmes:

  • Keratify (Dr Rosalind Hannen) – Skin culture platform to improve skin modelling and drug testing
  • Semantica (Dr Abdollahyan) – AI tool that analyses doctorpatient conversations for early detection of mental health problems
  • Happy Hub (Dr Sandra Jumbe) – Improving workplace productivity for large organisations through stress management
  • BioBreathe (Dr Rabia Lalani) – Breathing better for your biology: bespoke breathing techniques for relief of anxiety & digestive disease
  • Restoring Aged Skin (Matthew Caley) – From the Bottom Up – Combining high-throughput screening systems with compound libraries to identify compounds that reverse skin ageing.
  • AI-driven transcutaneous Vagal Nerve stimulation device (Professor Qasim Aziz) – We aim to develop a nonpharmacological device that can monitor an individual’s heart rate and predict visceral pain.

The funding has also leveraged a further £1,303,666 for QMUL in grants and investment for the projects.